Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of nitric oxide, prostaglandins, thromboxanes and endothelins in lung cancer: An overview. | World J Clin Cases | 2025 | 40881244 | PubTator, text mining | PubMed |
| Review of the Role of TRAF7 in Brain Endothelial Integrity and Cerebrovascular Aging. | Life (Basel) | 2025 | 40868928 | PubTator, text mining | PubMed |
| Combined Bioinformatic and Experimental Approaches to Analyze miR-182-3p and miR-24-3p Expression and Their Target Genes in Gestational Diabetes Mellitus and Iron Deficiency Anemia During Pregnancy. | Curr Issues Mol Biol | 2025 | 40864764 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers. | Noncoding RNA | 2025 | 40863727 | PubTator, text mining | PubMed |
| MicroRNA Signatures in Dental Pulp Stem Cells Following Nicotine Exposure. | Dent J (Basel) | 2025 | 40863041 | PubTator, text mining | PubMed |
| PER1 Serves as a Tumor Suppressor in Breast Cancer by Regulating MEK5/ERK5 Signaling Pathway. | Int J Gen Med | 2025 | 40809954 | PubTator, text mining | PubMed |
| Dichloroacetate enhances Chemo-sensitivity in wild-type P53 breast cancer cells by modulating ABCG2 and NKG2DL. | Sci Rep | 2025 | 40789868 | PubTator, text mining | PubMed |
| Mechanisms of Actinidia chinensis Planch roots in the treatment of breast cancer based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2025 | 40760645 | PubTator, text mining | PubMed |
| Circulating extra-cellular RNAs and atrial fibrillation: data from the TRACE-CORE cohort. | Front Cardiovasc Med | 2025 | 40734983 | PubTator, text mining | PubMed |
| TNIK-driven regulation of ERK5 transcriptional activity in endothelial cells. | Front Cardiovasc Med | 2025 | 40672381 | PubTator, text mining | PubMed |
| MAPK Signaling in the Interplay Between Oxidative Stress and Autophagy. | Antioxidants (Basel) | 2025 | 40563296 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase 1 regulates platelet function and thrombus formation. | J Thromb Haemost | 2025 | 40447106 | PubTator, text mining | PubMed |
| Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients. | EPMA J | 2025 | 40438489 | PubTator, text mining | PubMed |
| MicroRNA-27a regulates the viability, migration and invasion of human skin cancer cells by targeting MAPK7. | Arch Med Sci | 2025 | 40395888 | PubTator, text mining | PubMed |
| Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples. | BMC Cancer | 2025 | 40375170 | PubTator, text mining | PubMed |
| Mechanism of miR-143 regulating ERK5 signaling pathway-mediated manganese-induced striatal neuronal apoptosis. | Ecotoxicol Environ Saf | 2025 | 40367610 | PubTator, text mining | PubMed |
| Ankrd1 Promotes Lamellipodia Formation and Cell Motility via Interaction with Talin-1 in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2025 | 40362467 | PubTator, text mining | PubMed |
| Krüppel-like factors in mitochondrial quality control. | Front Physiol | 2025 | 40265156 | PubTator, text mining | PubMed |
| Anti-cancer Effects of 1,4-Dialkoxynaphthalene-Imidazolium Salt Derivatives through ERK5 kinase activity inhibition. | Sci Rep | 2025 | 40254676 | PubTator, text mining | PubMed |
| THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis. | Cell Rep | 2025 | 40222008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=5